Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: G-protein coupled receptor 64 (GPR64) acts as a tumor suppressor in endometrial cancer

Fig. 1

Levels of GPR64 in human endometrial cancer. a Representative immunohistochemistry andsemiquantitative analysis for GPR64 expression in control endometrium from women in proliferative, early, and mid-secretory phases. b Representative immunohistochemistry and semiquantitative analysis for GPR64 expression in endometrial cancer tissues. The semiquantitative analysis of immunohistochemistry analysis was calculated by H-score among 24 control endometrium and 21 endometrial cancer tissues. High level of GPR64 was observed in 100% control endometrium (6/6) and 52.38% endometrial cancer (11/21), and low level was observed in 47.62% endometrial cancer (10/21). ***, p < 0.001

Back to article page